The Financial and Work-Related Impact of Living with SMA Type 1, 2 or 3 for Unpaid Carers
05 March 2019
Thank you to all who responded to this survey that closed in January, and to Wickenstones for their analysis.
The results and the results of our survey last year about the impact of SMA are now available and are being used to inform Biogen’s continuing work with NICE re: access to nusinersen.
You can see a summary of the results by clicking on the link below: